Skip to main content

NEW YORK (TheStreet) -- Jefferies increased its price target on NuVasive  (NUVA) - Get NuVasive, Inc. Report to $48 from $45, increased its estimates and set a "buy" rating. The firm cited the company's strong second-quarter results and sustainable growth.

The stock closed at $35.06 on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

----------

Separately, TheStreet Ratings team rates NUVASIVE INC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate NUVASIVE INC (NUVA) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow."

TheStreet Recommends

You can view the full analysis from the report here: NUVA Ratings Report

Image placeholder title

NUVA

data by

YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.